Cargando…
Experience in patients with hidradenitis suppurativa and COVID-19 symptoms
Autores principales: | Galán, José Luis, Silvente, Catiana, González, Mónica, García, Claudia, Díez, Kevin, Martín, María Ángeles, Velázquez, Diana, de la Cueva, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320706/ https://www.ncbi.nlm.nih.gov/pubmed/32603717 http://dx.doi.org/10.1016/j.jaad.2020.06.986 |
Ejemplares similares
-
Hidradenitis suppurativa: The importance of virtual outpatient care during COVID-19 pandemic
por: Shah, Monica, et al.
Publicado: (2020) -
Exploring the risk of severe COVID-19 infection in patients with hidradenitis suppurativa
por: Seltzer, Janyla A., et al.
Publicado: (2020) -
Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic
por: Kearns, Donovan G., et al.
Publicado: (2020) -
Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations
por: Blaszczak, Alecia, et al.
Publicado: (2020) -
Comment on “The impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: A single institution experience”
por: McFeely, Orla, et al.
Publicado: (2021)